NCT01994330View on ClinicalTrials.gov

Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

February 28, 2010

Conditions
Acquired Von Willebrand Disease Secondary to Severe Aortic StenosisHeye´s SyndromeSevere Aortic Stenosis
Interventions
DRUG

desmopressin

0.3 mcg per kilogram administered in 30 minutes a half hour previous to surgical incision

Trial Locations (1)

Unknown

Hospital Clínico Universidad Católica de Chile, Santiago

Sponsors

Collaborators (1)

Ferring Pharmaceuticals
All Listed Sponsors
collaborator

Ferring Pharmaceuticals

INDUSTRY

lead

Pontificia Universidad Catolica de Chile

OTHER

NCT01994330 - Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery | Biotech Hunter | Biotech Hunter